share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Upadhyay Suketu

SEC ·  May 3 16:31

Summary by Moomoo AI

On May 1, 2024, Suketu Upadhyay, engaged in transactions involving Vertex Pharmaceuticals Inc. (VRTX) common stock. Upadhyay acquired 1,001 shares at no cost, which was reported as a grant, award, or other acquisition. On the same day, Upadhyay disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, Upadhyay's direct holdings in Vertex Pharmaceuticals amounted to 2,559 shares. The transactions have been marked as completed.
On May 1, 2024, Suketu Upadhyay, engaged in transactions involving Vertex Pharmaceuticals Inc. (VRTX) common stock. Upadhyay acquired 1,001 shares at no cost, which was reported as a grant, award, or other acquisition. On the same day, Upadhyay disposed of 1,168 shares; however, the transaction price was not disclosed. Following these transactions, Upadhyay's direct holdings in Vertex Pharmaceuticals amounted to 2,559 shares. The transactions have been marked as completed.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more